BPA Call VA25516A0068-VA25517J5653
- This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $105,966.01 firm fixed-price contract is for the supply of BIOFIRE BLOOD CULTURE products, utilizing Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract has an ultimate completion date of...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a Blanket Purchase Agreement (BPA) call order to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $146,700 contract is for the provision of virus, bacteria, and parasite detection systems, including molecular diagnostic testing services and products, COVID-19 testing reagents and equipment, and maintenance services for Biofire systems. This award was made...
- This is a federal contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $120,969.63 contract is for FilmArray Diagnostics Testing under a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has a completion date of...
- This is a federal contract award issued by the Veterans Integrated Service Network 15 (VISN 15) of the Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, a Blanket Purchase Agreement (BPA) Call, is for the provision of BIOFIRE CPRR products and services under Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's own General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The award, valued at $171,925.20, is for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to procure...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for the provision of molecular pathogen detection services. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents and tests. The $430,808.73 ceiling value contract has a firm fixed price pricing type and was awarded by the...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $302,904 contract is a Blanket Purchase Agreement (BPA) call under Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and test kits. The contract supports the VA's COVID-19 response, with Biofire providing molecular...
- This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The award, valued at $1,598,542.00, is for molecular pathogen detection products and services. The contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its Veterans Integrated Service Network (VISN) 8. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract, which has a potential value of $883,594.79, is a Blanket Purchase Agreement (BPA) call under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The...
- This federal contract award was made by the Veterans Integrated Service Network (VISN) 23 of the U.S. Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $269,604.12 firm fixed-price contract is for the provision of PCR lab testing kits to be delivered by September 30, 2024. This award is a call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- V797D30085-VA25516A0068Blanket Purchase Agreement
- VA25516A0068-VA25517J5653BPA Call
This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a biotech company that specializes in syndromic infectious disease testing. The $351,315.66 award is for BIOFIRE CPRR WITH INSTRUMENTATION, with a completion date of January 4, 2019. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. No set-aside designation was used. Biofire Diagnostics LLC has received numerous federal contract awards as a prime contractor to provide a variety of goods and services related to infectious disease testing, including for COVID-19, to the VA, Defense Health Agency, Indian Health Service, and Department of State.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($62k) | 1/4/19 | |
| Not listed | Not listed | $152.0k | 9/12/17 |